Skip to main content
. Author manuscript; available in PMC: 2014 Dec 17.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Apr 18;4:CD001430. doi: 10.1002/14651858.CD001430.pub3

Comparison 2. Oral corticosteroids versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Participants with normal visual acuity 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
 1.1 Patients with normal visual acuity at 6 months 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 1.2 Patients with normal visual acuity at 1 year 3 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 1.3 Patients with normal visual acuity at 1 month 3 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Participants with normal contrast sensitivity 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
 2.1 Patients with normal contrast sensitivity at 6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 2.2 Patients with normal contrast sensitivity at 1 year 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 2.3 Patients with normal contrast sensitivity at 1 month 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Participants with normal visual field 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
 3.1 Patients with normal visual field at 6 months 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 3.2 Patients with normal 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Patients with normal visual field at 1 month 2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]